AFT shares drop 6.3% after ticking off over Maxiclear marketing

Paul McBeth
Wed, 16 Aug 2017

By Paul McBeth Aug. 16 (BusinessDesk) - AFT Pharmaceutical shares dropped 6.3 percent on very thin volumes after the maker of Maxigesic was one of two companies warned by the Commerce Commission over the marketing and packaging of painkillers.  The shares fell 18 cents to $2.66 with just 5,000 shares changing hands after the regulator said it warned AFT and GlaxoSmithKline Consumer Healthcare New Zealand that the packaging and marketing of various painkillers probably breached the Fair Trading Act by claiming to treat specific ailments. T...

Not convinced yet?

Subscribe to our Daily News Update free newsletter.

Primary Sector
Another class action against A2, this time in Auckland
Rebecca Howard | Wed, 18 May 2022

The opt-in class action has been filed in the Auckland High Court and already includes one financial institution. 

Argosy's property income slips as portfolio's value rises
Jenny Ruth | Wed, 18 May 2022

Argosy will pay out more in dividends than adjusted funds from operations, as foreshadowed a year ago.

Primary Sector
Fed Farmers' Lewis stepping down after 17 years
Rebecca Howard | Wed, 18 May 2022

Federated Farmers board member Chris Lewis said it was time for change within the organisation.

Partner content
What’s driving the ram raids, and what shop owners can do

Scott La Franchie explains the motivations behind the spate of burglaries.

Partner content
Grow your business by taking time to plan

Getting business fundamentals right gives the best chance at beating the unplannable.